Latent Tuberculosis Infection
📧 Sign up to get email alerts when something new happens for Latent Tuberculosis Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above [Phase 3]
Phase 3 clinical trial evaluating a recombinant Mycobacterium tuberculosis fusion protein for latent tuberculosis infection in adults aged 6…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Active clinical trial recruiting to screen school contacts of active TB patients for latent tuberculosis infection.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Evaluating the Accuracy of New Tests for TB Infection Diagnosis [NA]
This document reports on a completed clinical trial evaluating the accuracy of new tests for diagnosing TB infection, including latent tuber…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: 1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam [Phase 3]
Phase 3 clinical trial in Vietnam comparing 1HP (isoniazid + rifapentine) to 3HR (isoniazid + rifampin) for latent tuberculosis infection; t…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals [Phase 3]
Phase 3 clinical trial update on preventive therapy for latent tuberculosis infection in HIV-infected individuals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT [Phase 3]
A Phase 3 trial comparing adherence to the 3HP latent tuberculosis infection regimen under self-administered therapy (SAT) versus directly o…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Latent Tuberculosis in Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update examining latent tuberculosis infection in individuals with type 2 diabetes. The study is currently active but…
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid submitted by Chartwell RX, LLC.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for isoniazid submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Marlex Pharmaceuticals, Inc.)
FDA approved a supplemental application for Isoniazid from Marlex Pharmaceuticals, approving changes to the previously approved product.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid (isoniazid) submitted by Chartwell RX, LLC.
-
FDA approval · 2025-01-30FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid from Chartwell RX, LLC, authorizing changes to the previously approved product.
-
FDA approval · 2025-01-29FDA Approved: ISONIAZID — Supplemental Application (CMP Pharma, Inc.)
FDA approved CMP Pharma, Inc.'s supplemental application for isoniazid, updating the approved product under an abbreviated new drug applicat…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Lung Innate Immunity and Microbiome After Tuberculosis Exposure
Ongoing University of Oxford clinical trial investigates how the lung innate immune system and microbiome respond after exposure to tubercul…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
A clinical trial examining patients with mycobacterial infections, tuberculosis, or latent tuberculosis is currently recruiting at IRCCS Azi…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention [Phase 1]
Phase 1 pharmacokinetics study assessing dolutegravir when co-administered with weekly rifapentine/isoniazid for TB prevention in pediatric …
-
FDA approval · 2024-10-24FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for isoniazid from Teva Pharmaceuticals USA, Inc., confirming regulatory clearance for this gene…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia
This completed clinical trial update studied how HIV seropositivity and tuberculosis affect the epidemiology, clinical trajectory, virology,…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI [Phase 2, Phase 3]
A clinical trial update describing a Phase 2/Phase 3 study of daily rifapentine for latent tuberculosis infection, focusing on safety, toler…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein [Phase 4]
A Phase 4 trial evaluating a recombinant Mycobacterium tuberculosis fusion protein for latent tuberculosis infection has been completed.
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Immunological Biomarkers in Tuberculosis Management [NA]
A clinical trial in Lyon is evaluating immunological biomarkers to improve tuberculosis management and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals [Phase 2]
This Phase 2 trial investigated drug-drug interactions between rifapentine and dolutegravir in people co-infected with HIV and latent TB inf…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Improving Rhode Island's Tuberculosis Preventive Services in Primary Care [NA]
A completed clinical trial assessing strategies to improve latent tuberculosis infection preventive services in primary care settings in Rho…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
Clinical trial evaluating rifampicin resistance in Staphylococcus aureus during and after treatment for latent tuberculosis is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection [NA]
A Bahir Dar University-led trial evaluating the integration of traditional tuberculosis care with modern health services has completed. The …